Qured raises £620k in new funding as part of an ongoing seed round.
The funding was secured via an advanced subscription agreement from backers including Lexham Partners and Araya Ventures.
Qured provides a prevention-as-a-service platform designed to improve workforce wellbeing and health screening. The company delivers home health screening and personalised interventions for corporate clients.
Qured has secured £620k in new funding through an advanced subscription agreement, forming part of a broader £1.5m seed round that remains open for further commitments.
The capital was backed by returning investor Lexham Partners alongside new participants Araya Ventures, Korra Ventures, LBS E100, and several angel investors including chairman Prof. Sneh Khemka CBE.
The company will use the proceeds to accelerate its growth across the UK, drive towards profitability, and prepare for international expansion.
From the founder
"We’re on a mission to end the crisis in workforce health by making preventative healthcare scalable, measurable, and accessible. This investment will accelerate our growth in the UK, take us to profitability, and set the stage for international expansion."
Alex Templeton
CEO and co-founder at Qured
Use of funds
- 01Expand into international markets